INTERCEPT PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INTERCEPT PHARMACEUTICALS IN CALL, CUSIP 45845P908.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INTERCEPT PHARMACEUTICALS IN CALL, CUSIP 45845P908.